Garcia Hamilton & Associates LP DE lowered its holdings in Cigna Corporation (NYSE:CI) by 37.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 5,030 shares of the health services provider’s stock after selling 2,954 shares during the quarter. Cigna Corporation makes up 1.2% of Garcia Hamilton & Associates LP DE’s portfolio, making the stock its 25th biggest position. Garcia Hamilton & Associates LP DE’s holdings in Cigna Corporation were worth $842,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. American Beacon Advisors Inc. bought a new stake in shares of Cigna Corporation in the 1st quarter valued at about $102,000. Capstone Investment Advisors Netherlands B.V. bought a new stake in shares of Cigna Corporation in the 2nd quarter valued at about $106,000. Parallel Advisors LLC raised its holdings in shares of Cigna Corporation by 62.3% in the 2nd quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after purchasing an additional 307 shares in the last quarter. Guardian Life Insurance Co. of America raised its holdings in shares of Cigna Corporation by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after purchasing an additional 7 shares in the last quarter. Finally, Acrospire Investment Management LLC raised its holdings in shares of Cigna Corporation by 66.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the health services provider’s stock valued at $167,000 after purchasing an additional 400 shares in the last quarter. Institutional investors and hedge funds own 87.94% of the company’s stock.
In other Cigna Corporation news, VP Mary T. Hoeltzel sold 525 shares of the firm’s stock in a transaction that occurred on Wednesday, August 9th. The shares were sold at an average price of $177.59, for a total transaction of $93,234.75. Following the sale, the vice president now owns 1,924 shares of the company’s stock, valued at $341,683.16. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Jason D. Sadler sold 37,756 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $176.16, for a total transaction of $6,651,096.96. Following the sale, the insider now directly owns 47,844 shares in the company, valued at approximately $8,428,199.04. The disclosure for this sale can be found here. In the last three months, insiders have sold 70,653 shares of company stock worth $12,437,684. 1.30% of the stock is owned by corporate insiders.
Several research firms have recently commented on CI. Zacks Investment Research upgraded shares of Cigna Corporation from a “hold” rating to a “buy” rating and set a $214.00 price target for the company in a report on Monday. Piper Jaffray Companies restated a “buy” rating and issued a $191.00 price target on shares of Cigna Corporation in a report on Sunday, September 17th. BidaskClub upgraded shares of Cigna Corporation from a “buy” rating to a “strong-buy” rating in a report on Friday, August 18th. Morgan Stanley boosted their price target on shares of Cigna Corporation from $188.00 to $195.00 and gave the company an “overweight” rating in a report on Thursday, August 17th. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $185.00 price target on shares of Cigna Corporation in a report on Wednesday, August 9th. One investment analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $190.27.
Shares of Cigna Corporation (CI) traded up 0.02% on Thursday, reaching $186.99. 608,056 shares of the company’s stock were exchanged. Cigna Corporation has a one year low of $115.03 and a one year high of $193.00. The firm has a market capitalization of $47.08 billion, a P/E ratio of 21.57 and a beta of 0.43. The firm has a 50 day moving average of $184.75 and a 200 day moving average of $169.73.
Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company had revenue of $10.32 billion for the quarter, compared to analysts’ expectations of $10.26 billion. During the same quarter last year, the company earned $1.98 earnings per share. The firm’s revenue for the quarter was up 3.6% on a year-over-year basis. On average, equities research analysts predict that Cigna Corporation will post $10.03 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.com-unik.info/2017/10/12/garcia-hamilton-associates-lp-de-sells-2954-shares-of-cigna-corporation-ci.html.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Corporation (NYSE:CI).
What are top analysts saying about Cigna Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cigna Corporation and related companies.